四川省天基生物药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
36
NMPA:36
Drug Approvals
Moroxydine Hydrochloride Tablets
- Product Name
- 盐酸吗啉胍片
- Approval Number
- 国药准字H51023915
- Approval Date
- Sep 30, 2020
NMPA
Berberine Hydrochloride Tablets
- Product Name
- 盐酸小檗碱片
- Approval Number
- 国药准字H51021592
- Approval Date
- Sep 30, 2020
NMPA
Roxithromycin Dispersible Tablets
- Product Name
- 罗红霉素分散片
- Approval Number
- 国药准字H20000181
- Approval Date
- Jan 15, 2020
NMPA
Ranitidine Hydrochloride Capsules
- Product Name
- 盐酸雷尼替丁胶囊
- Approval Number
- 国药准字H51021590
- Approval Date
- Jan 15, 2020
NMPA
Berberine Hydrochloride Tablets
- Product Name
- 盐酸小檗碱片
- Approval Number
- 国药准字H51021591
- Approval Date
- Jan 15, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found